Unicycive to raise $26M in an IPO valuing the company at nearly $116M (Pending:UNCY)

Unicycive Therapeutics (UNCY) a biotechnology company focused on kidney diseases is set to offer ~2.6M shares in an IPO priced at$8.50 and $10.50 apiece.The underwriters have an option…
Read More